For how long can the new fund distribution of the old?

October 29, 2018 Latest News Comment

This is a preview of subscriber content

Subscribe now to continue reading.

In 2020 will the maker of a new immunotherapy be willing to give up even more of the value of their new hospital administered cancer treatment through statutory price reductions to fund the cost of distributing old and commoditised generic medicines? …

Subscribe now to continue reading.

Latest Video

Australian study finds maternal RSV vaccination offers strong protection for infants
August 25, 2026 - Latest News
Avecho moves to deepen global partnering push as CBD insomnia program advances
August 24, 2026 - Australian Biotech
Acrux brings experienced clinical leader aboard to advance testosterone program
August 24, 2026 - Australian Biotech
Insurers warn cut could hit Australians most likely to need cancer care
August 25, 2026 - Latest News
Australia cannot deliver meaningful change until the levers of power are rebalanced
August 26, 2026 - Latest News

For how long can the new fund distribution of the old?

This is a preview of subscriber content

Latest Video

Most Read

Australian study finds maternal RSV vaccination offers strong protection for infants

Avecho moves to deepen global partnering push as CBD insomnia program advances

Acrux brings experienced clinical leader aboard to advance testosterone program

Insurers warn cut could hit Australians most likely to need cancer care

Australia cannot deliver meaningful change until the levers of power are rebalanced

New Stories

Cathy Freeman to headline 2026 Patient’s Choice Awards

Australian company secures Mitsubishi partnership to bring BioPQQ to market

Noxopharm pushes Sofra platform towards cancer proof of concept

Argent BioPharma takes CannEpil into US veterinary regulatory process

Entropy takes TRP-8803 to the US in head-to-head depression trial

Neuren’s first dividend signals a new phase built on DAYBUE royalties

Starpharma narrows loss as Genentech deal lifts revenue and new funding extends runway

Sign In

For how long can the new fund distribution of the old?

This is a preview of subscriber content

Latest Video

Most Read

Australian study finds maternal RSV vaccination offers strong protection for infants

Avecho moves to deepen global partnering push as CBD insomnia program advances

Acrux brings experienced clinical leader aboard to advance testosterone program

Insurers warn cut could hit Australians most likely to need cancer care

Australia cannot deliver meaningful change until the levers of power are rebalanced

Follow Us

New Stories

Cathy Freeman to headline 2026 Patient’s Choice Awards

Australian company secures Mitsubishi partnership to bring BioPQQ to market

Noxopharm pushes Sofra platform towards cancer proof of concept

Argent BioPharma takes CannEpil into US veterinary regulatory process

Entropy takes TRP-8803 to the US in head-to-head depression trial

Neuren’s first dividend signals a new phase built on DAYBUE royalties

Starpharma narrows loss as Genentech deal lifts revenue and new funding extends runway